Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| LIFECORE BIOMEDICAL, INC. \DE\LFCR · Entity 6447 | Director | June 04, 2026 | June 05, 2026 |
| SunOpta Inc.STKL · Entity 49798 | Director | May 29, 2024 | May 31, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
LIFECORE BIOMEDICAL, INC. \DE\
Report date June 04, 2026 · Filed June 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 135,319 |
Reported balance
After 2026-06-04 transaction · row 1
1 source rowRow 1 · 2026-06-04 · Grant · Acquired 25,907 · Balance 135,319 F1: The restricted stock units convert into common stock of Lifecore Biomedical, Inc. on a 1 for 1 basis. F2: Vests on earlier of June 4, 2027 or the date of the annual meeting of stockholders of the Company first held in calendar year 2027 (provided such date is no less than 50 weeks from June 4, 2026). |
Filing footnotes · ownership attribution and instrument terms
F1: The restricted stock units convert into common stock of Lifecore Biomedical, Inc. on a 1 for 1 basis.
F2: Vests on earlier of June 4, 2027 or the date of the annual meeting of stockholders of the Company first held in calendar year 2027 (provided such date is no less than 50 weeks from June 4, 2026).
SunOpta Inc.
Report date May 29, 2024 · Filed May 31, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common SharesSEC Table I · non-derivative | Direct | 216,869 |
Reported balance
After 2024-05-30 transaction · row 1
1 source rowRow 1 · 2024-05-30 · Exercise / conversion · Acquired 15,283 · Balance 216,869 F1: Each Restricted Stock Unit represents a contingent right to receive one share of STKL common stock. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 20,072 |
Reported balance
After 2024-05-29 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2024-05-29 · Grant · Acquired 20,072 · Balance 20,072 F1: Each Restricted Stock Unit represents a contingent right to receive one share of STKL common stock. F2: The Restricted Stock Units do not have an expiration date. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2024-05-30 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2024-05-30 · Exercise / conversion · Disposed 15,283 · Balance 0 F1: Each Restricted Stock Unit represents a contingent right to receive one share of STKL common stock. F2: The Restricted Stock Units do not have an expiration date. |
Filing footnotes · ownership attribution and instrument terms
F1: Each Restricted Stock Unit represents a contingent right to receive one share of STKL common stock.
F2: The Restricted Stock Units do not have an expiration date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 04, 2026 Filed Jun 5, 2026 20:44 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LFCR · Entity 6447 | GrantCommon Stock | 25,907 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001269294-26-000002 · wk-form4_1780692247.xml · nonDerivative · entry 1 HOUDE LOVAS KATRINA · CIK 0001269294 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 135,319 F1 · price: The restricted stock units convert into common stock of Lifecore Biomedical, Inc. on a 1 for 1 basis. F2 · price: Vests on earlier of June 4, 2027 or the date of the annual meeting of stockholders of the Company first held in calendar year 2027 (provided such date is no less than 50 weeks from June 4, 2026). Read SEC document |
| July 15, 2025 Filed Jul 17, 2025 20:36 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LFCR · Entity 6447 | GrantCommon Stock | 19,506 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001005286-25-000087 · wk-form4_1752784568.xml · nonDerivative · entry 1 HOUDE LOVAS KATRINA · CIK 0001269294 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 109,412 F1 · price: The restricted stock units convert into common stock of Lifecore Biomedical, Inc. on a 1 for 1 basis. F2 · price: Vests on the earlier of the one year anniversary of the date hereof or the date of the annual meeting of stockholders of the Company first held in calendar year 2026 (provided such date is no less than 50 weeks from the date hereof). Read SEC document |
| July 08, 2024 Filed Jul 10, 2024 23:44 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LFCR · Entity 6447 | GrantCommon Stock | 30,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-24-031628 · wk-form4_1720655057.xml · nonDerivative · entry 1 HOUDE LOVAS KATRINA · CIK 0001269294 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 89,906 F1 · price: The restricted stock units convert into common stock of Lifecore Biomedical, Inc. on a 1 for 1 basis. F2 · price: Vests on earlier of the first anniversary of the grant date or the date of the annual meeting of stockholders first held in calendar year 2025, subject to potential acceleration. Read SEC document |
| May 30, 2024 Filed May 31, 2024 23:28 UTC | SunOpta Inc. STKL · Entity 49798 | Exercise / conversionRestricted Stock Units · Derivative | 15,283 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-011583 · form4.xml · derivative · entry 3 HOUDE LOVAS KATRINA · CIK 0001269294 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 15,283 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of STKL common stock. F2 · derivative.expiration_date: The Restricted Stock Units do not have an expiration date. Read SEC document |
| May 30, 2024 Filed May 31, 2024 23:28 UTC | SunOpta Inc. STKL · Entity 49798 | Exercise / conversionCommon Shares | 15,283 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001062993-24-011583 · form4.xml · nonDerivative · entry 1 HOUDE LOVAS KATRINA · CIK 0001269294 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 216,869 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents a contingent right to receive one share of STKL common stock. Read SEC document |
| May 29, 2024 Filed May 31, 2024 23:28 UTC | SunOpta Inc. STKL · Entity 49798 | GrantRestricted Stock Units · Derivative | 20,072 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-011583 · form4.xml · derivative · entry 2 HOUDE LOVAS KATRINA · CIK 0001269294 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,072 Underlying: Common Shares · 20,072 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of STKL common stock. F2 · derivative.expiration_date: The Restricted Stock Units do not have an expiration date. Read SEC document |
| February 01, 2024 Filed Feb 2, 2024 23:31 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LFCR · Entity 6447 | Exercise / conversionRestricted Stock Unit · Derivative | 9,554 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-003128 · wk-form4_1706916694.xml · derivative · entry 2 HOUDE LOVAS KATRINA · CIK 0001269294 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,554 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The restricted stock units convert into common stock of Lifecore Biomedical, Inc. on a 1 for 1 basis. F2 · derivative.expiration_date: The restricted stock units vested on February 1, 2024. Read SEC document |
| February 01, 2024 Filed Feb 2, 2024 23:31 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LFCR · Entity 6447 | Exercise / conversionCommon Stock | 9,554 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-24-003128 · wk-form4_1706916694.xml · nonDerivative · entry 1 HOUDE LOVAS KATRINA · CIK 0001269294 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,906 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The restricted stock units convert into common stock of Lifecore Biomedical, Inc. on a 1 for 1 basis. Read SEC document |
| August 21, 2023 Filed Aug 23, 2023 20:08 UTC | SunOpta Inc. STKL · Entity 49798 | SaleCommon Shares | 45,000 | $4.40 | $198,063.00 |
DisclosureSEC source: 0001209191-23-047028 · doc4.xml · nonDerivative · entry 1 HOUDE LOVAS KATRINA · CIK 0001269294 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 201,586 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.40 to $4.42, inclusive. The reporting person undertakes to provide to SunOpta Inc., any security holder of SunOpta Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4. Read SEC document |
| June 06, 2023 Filed Jun 8, 2023 20:09 UTC | SunOpta Inc. STKL · Entity 49798 | Exercise / conversionRestricted Stock Units · Derivative | 14,018 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-035364 · doc4.xml · derivative · entry 2 HOUDE LOVAS KATRINA · CIK 0001269294 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 14,018 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of STKL common stock. F2 · derivative.expiration_date: The Restricted Stock Units do not have an expiration date. Read SEC document |
| June 06, 2023 Filed Jun 8, 2023 20:09 UTC | SunOpta Inc. STKL · Entity 49798 | Exercise / conversionCommon Shares | 14,018 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-035364 · doc4.xml · nonDerivative · entry 1 HOUDE LOVAS KATRINA · CIK 0001269294 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 246,586 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents a contingent right to receive one share of STKL common stock. Read SEC document |
| June 01, 2023 Filed Jun 5, 2023 19:10 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LFCR · Entity 6447 | GrantCommon Stock | 18,182 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-23-020828 · wk-form4_1685992218.xml · nonDerivative · entry 1 HOUDE LOVAS KATRINA · CIK 0001269294 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,352 F1 · price: The restricted stock units convert into common stock of Lifecore Biomedical, Inc. on a 1 for 1 basis. F2 · price: Restricted Stock Units will vest and be settled on the earlier of the 1st anniversary of the grant date or the date of the 2024 Annual Meeting of Stockholders (provided such date is no less than 50 weeks from Grant Date). Read SEC document |
| May 31, 2023 Filed Jun 1, 2023 22:57 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LFCR · Entity 6447 | Exercise / conversionRestricted Stock Unit · Derivative | 9,474 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-020578 · wk-form4_1685660228.xml · derivative · entry 2 HOUDE LOVAS KATRINA · CIK 0001269294 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,474 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The restricted stock units convert into common stock of Lifecore Biomedical, Inc. on a 1 for 1 basis. F2 · derivative.exercise_date: The restricted stock units vested on May 31, 2023. F2 · derivative.expiration_date: The restricted stock units vested on May 31, 2023. Read SEC document |
| May 31, 2023 Filed Jun 1, 2023 22:57 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LFCR · Entity 6447 | Exercise / conversionCommon Stock | 9,474 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-23-020578 · wk-form4_1685660228.xml · nonDerivative · entry 1 HOUDE LOVAS KATRINA · CIK 0001269294 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,170 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The restricted stock units convert into common stock of Lifecore Biomedical, Inc. on a 1 for 1 basis. F2 · price: The restricted stock units vested on May 31, 2023. Read SEC document |
| May 30, 2023 Filed Jun 1, 2023 21:12 UTC | SunOpta Inc. STKL · Entity 49798 | GrantRestricted Stock Units · Derivative | 15,283 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-033372 · doc4.xml · derivative · entry 1 HOUDE LOVAS KATRINA · CIK 0001269294 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,283 Underlying: Common Shares · 15,283 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of STKL common stock. F2 · derivative.expiration_date: The Restricted Stock Units do not have an expiration date. Read SEC document |
| February 02, 2023 Filed Feb 6, 2023 21:28 UTC | SunOpta Inc. STKL · Entity 49798 | GrantCommon Shares | 1,700 | $8.21 | $13,957.00 |
DisclosureSEC source: 0001209191-23-007285 · doc4.xml · nonDerivative · entry 1 HOUDE LOVAS KATRINA · CIK 0001269294 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 232,568 F1 · kind: The shares were issued in lieu of cash to the reporting person for service on the board of directors. Read SEC document |
| February 01, 2023 Filed Feb 2, 2023 22:31 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LFCR · Entity 6447 | GrantRestricted Stock Unit · Derivative | 9,554 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-23-002099 · wf-form4_167537704631736.xml · derivative · entry 1 HOUDE LOVAS KATRINA · CIK 0001269294 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,554 Underlying: Common Stock · 9,554 shares Expires not disclosed F1 · derivative.exercise_price: The Restricted Stock Units convert into common stock of Lifecore Biomedical, Inc. on a 1 for 1 basis. F1 · price: The Restricted Stock Units convert into common stock of Lifecore Biomedical, Inc. on a 1 for 1 basis. F2 · derivative.expiration_date: Restricted Stock Units will vest on the 1st anniversary of the grant date and will be automatically settled in shares of common stock. Read SEC document |
| October 21, 2022 Filed Oct 24, 2022 21:58 UTC | SunOpta Inc. STKL · Entity 49798 | GrantCommon Shares | 1,501 | $9.93 | $14,904.93 |
DisclosureSEC source: 0001209191-22-054439 · doc4.xml · nonDerivative · entry 1 HOUDE LOVAS KATRINA · CIK 0001269294 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 230,868 F1 · kind: The shares were issued in lieu of cash to the reporting person for service on the board of directors. Read SEC document |
| July 29, 2022 Filed Aug 3, 2022 13:54 UTC | SunOpta Inc. STKL · Entity 49798 | GrantCommon Shares | 1,977 | $8.82 | $17,437.14 |
DisclosureSEC source: 0001209191-22-044047 · doc4.xml · nonDerivative · entry 1 HOUDE LOVAS KATRINA · CIK 0001269294 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 229,367 F1 · kind: The shares were issued in lieu of cash to the reporting person for service on the board of directors. Read SEC document |
| June 07, 2022 Filed Jun 9, 2022 20:14 UTC | SunOpta Inc. STKL · Entity 49798 | GrantRestricted Stock Units · Derivative | 14,018 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-035370 · doc4.xml · derivative · entry 1 HOUDE LOVAS KATRINA · CIK 0001269294 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,018 Underlying: Common Shares · 14,018 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of STKL common stock. F2 · derivative.expiration_date: The Restricted Stock Units do not have an expiration date. Read SEC document |
| June 04, 2022 Filed Jun 7, 2022 21:18 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionRestricted Stock Unit · Derivative | 7,059 | $9.50 | $67,060.50 |
DisclosureSEC source: 0001628280-22-016490 · wf-form4_165463667917133.xml · derivative · entry 2 HOUDE LOVAS KATRINA · CIK 0001269294 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,059 shares Expires 2022-06-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F2 · shares: The restricted stock units were granted on June 4, 2021. F3 · derivative.exercise_date: The restricted stock units vested on June 4, 2022. F3 · derivative.expiration_date: The restricted stock units vested on June 4, 2022. Read SEC document |
| June 04, 2022 Filed Jun 7, 2022 21:18 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | GrantCommon Stock | 7,059 | $9.50 | $67,060.50 |
DisclosureSEC source: 0001628280-22-016490 · wf-form4_165463667917133.xml · nonDerivative · entry 1 HOUDE LOVAS KATRINA · CIK 0001269294 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,696 F1 · price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 22:14 UTC | SunOpta Inc. STKL · Entity 49798 | Exercise / conversionRestricted Stock Units · Derivative | 7,503 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-034322 · doc4.xml · derivative · entry 2 HOUDE LOVAS KATRINA · CIK 0001269294 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 7,503 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of STKL common stock. F2 · derivative.expiration_date: The Restricted Stock Units do not have an expiration date. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 22:14 UTC | SunOpta Inc. STKL · Entity 49798 | Exercise / conversionCommon Shares | 7,503 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-034322 · doc4.xml · nonDerivative · entry 1 HOUDE LOVAS KATRINA · CIK 0001269294 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 227,390 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents a contingent right to receive one share of STKL common stock. Read SEC document |
| May 31, 2022 Filed Jun 2, 2022 16:47 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | GrantRestricted Stock Unit · Derivative | 9,474 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-22-016013 · wf-form4_165418842804084.xml · derivative · entry 1 HOUDE LOVAS KATRINA · CIK 0001269294 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,474 Underlying: Common Stock · 9,474 shares Expires not disclosed F1 · derivative.exercise_price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F1 · price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F2 · derivative.expiration_date: Restricted Stock Units will vest on the 1st anniversary of the grant date and will be automatically settled in shares of common stock. Read SEC document |
| April 22, 2022 Filed Apr 27, 2022 01:12 UTC | SunOpta Inc. STKL · Entity 49798 | GrantCommon Shares | 2,807 | $5.48 | $15,382.36 |
DisclosureSEC source: 0001209191-22-025709 · doc4.xml · nonDerivative · entry 1 HOUDE LOVAS KATRINA · CIK 0001269294 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 219,887 F1 · kind: The shares were issued in lieu of cash to the reporting person for service on the board of directors. Read SEC document |
| February 03, 2022 Filed Feb 7, 2022 21:55 UTC | SunOpta Inc. STKL · Entity 49798 | GrantCommon Shares | 2,062 | $6.95 | $14,330.90 |
DisclosureSEC source: 0001209191-22-007488 · doc4.xml · nonDerivative · entry 1 HOUDE LOVAS KATRINA · CIK 0001269294 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 217,080 F1 · kind: The shares were issued in lieu of cash to the reporting person for service on the board of directors. Read SEC document |
| October 22, 2021 Filed Oct 26, 2021 22:25 UTC | SunOpta Inc. STKL · Entity 49798 | GrantCommon Shares | 1,748 | $8.78 | $15,347.44 |
DisclosureSEC source: 0001209191-21-061695 · doc4.xml · nonDerivative · entry 1 HOUDE LOVAS KATRINA · CIK 0001269294 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 215,018 F1 · kind: The shares were issued in lieu of cash to the reporting person for service on the board of directors. Read SEC document |
| July 30, 2021 Filed Aug 4, 2021 01:46 UTC | SunOpta Inc. STKL · Entity 49798 | GrantCommon Shares | 1,213 | $12.26 | $14,871.38 |
DisclosureSEC source: 0001209191-21-049524 · doc4.xml · nonDerivative · entry 1 HOUDE LOVAS KATRINA · CIK 0001269294 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 213,270 F1 · kind: The shares were issued in lieu of cash to the reporting person for service on the board of directors. Read SEC document |
| June 22, 2021 Filed Jun 24, 2021 23:53 UTC | SunOpta Inc. STKL · Entity 49798 | Exercise / conversionRestricted Stock Units · Derivative | 19,547 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-043169 · doc4.xml · derivative · entry 3 HOUDE LOVAS KATRINA · CIK 0001269294 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 19,547 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of STKL common stock. F2 · derivative.expiration_date: The Restricted Stock Units do not have an expiration date. Read SEC document |
| June 22, 2021 Filed Jun 24, 2021 23:53 UTC | SunOpta Inc. STKL · Entity 49798 | Tax withholdingCommon Shares | 10,464 | $12.21 | $127,765.44 |
DisclosureSEC source: 0001209191-21-043169 · doc4.xml · nonDerivative · entry 2 HOUDE LOVAS KATRINA · CIK 0001269294 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 212,057 Read SEC document |
| June 22, 2021 Filed Jun 24, 2021 23:53 UTC | SunOpta Inc. STKL · Entity 49798 | Exercise / conversionCommon Shares | 19,547 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-043169 · doc4.xml · nonDerivative · entry 1 HOUDE LOVAS KATRINA · CIK 0001269294 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 222,521 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents a contingent right to receive one share of STKL common stock. Read SEC document |
| June 04, 2021 Filed Jun 8, 2021 23:56 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | GrantRestricted Stock Unit · Derivative | 7,059 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001593968-21-001567 · primary_01.xml · derivative · entry 1 HOUDE LOVAS KATRINA · CIK 0001269294 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,059 Underlying: Common Stock · 7,059 shares Expires not disclosed F1 · derivative.exercise_price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F1 · price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F2 · derivative.expiration_date: Restricted Stock Units will vest on the 1st anniversary of the grant date and will be automatically settled in shares of common stock. Read SEC document |
| June 01, 2021 Filed Jun 4, 2021 01:05 UTC | SunOpta Inc. STKL · Entity 49798 | GrantRestricted Stock Units · Derivative | 7,503 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-038065 · doc4.xml · derivative · entry 1 HOUDE LOVAS KATRINA · CIK 0001269294 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,503 Underlying: Common Shares · 7,503 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of STKL common stock. F2 · derivative.expiration_date: The Restricted Stock Units do not have an expiration date. Read SEC document |
| June 01, 2021 Filed Jun 4, 2021 00:07 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionRestricted Stock Unit · Derivative | 8,303 | $11.64 | $96,646.92 |
DisclosureSEC source: 0001593968-21-001524 · primary_01.xml · derivative · entry 2 HOUDE LOVAS KATRINA · CIK 0001269294 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,303 shares Expires 2021-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F2 · shares: The restricted stock units were granted on June 1, 2020. F3 · derivative.exercise_date: The restricted stock units vested on June 1, 2021. F3 · derivative.expiration_date: The restricted stock units vested on June 1, 2021. Read SEC document |
| June 01, 2021 Filed Jun 4, 2021 00:07 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | GrantCommon Stock | 8,303 | $11.64 | $96,646.92 |
DisclosureSEC source: 0001593968-21-001524 · primary_01.xml · nonDerivative · entry 1 HOUDE LOVAS KATRINA · CIK 0001269294 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,637 F1 · price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. Read SEC document |
| April 23, 2021 Filed Apr 26, 2021 20:12 UTC | SunOpta Inc. STKL · Entity 49798 | GrantCommon Shares | 1,155 | $14.84 | $17,140.20 |
DisclosureSEC source: 0001209191-21-028266 · doc4.xml · nonDerivative · entry 1 HOUDE LOVAS KATRINA · CIK 0001269294 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 202,974 F1 · kind: The shares were issued in lieu of cash to the reporting person for service on the board of directors. Read SEC document |
| January 29, 2021 Filed Feb 3, 2021 01:47 UTC | SunOpta Inc. STKL · Entity 49798 | GrantCommon Shares | 1,190 | $11.67 | $13,887.30 |
DisclosureSEC source: 0001209191-21-007010 · doc4.xml · nonDerivative · entry 1 HOUDE LOVAS KATRINA · CIK 0001269294 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 201,819 F1 · kind: The shares were issued in lieu of cash to the reporting person for service on the board of directors. Read SEC document |
| October 23, 2020 Filed Oct 26, 2020 21:12 UTC | SunOpta Inc. STKL · Entity 49798 | GrantCommon Shares | 1,733 | $7.34 | $12,720.22 |
DisclosureSEC source: 0001209191-20-055829 · doc4.xml · nonDerivative · entry 1 HOUDE LOVAS KATRINA · CIK 0001269294 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,629 F1 · kind: The shares were issued in lieu of cash to the reporting person for service on the board of directors. Read SEC document |
| October 15, 2020 Filed Oct 19, 2020 20:25 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | Exercise / conversionRestricted Stock Unit · Derivative | 7,334 | $0.00 | $0.00 |
DisclosureSEC source: 0001593968-20-002074 · primary_01.xml · derivative · entry 2 HOUDE LOVAS KATRINA · CIK 0001269294 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,334 shares Expires 2020-10-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F2 · shares: The restricted stock units were granted on October 15, 2019. F3 · derivative.exercise_date: The restricted stock units vested on October 15, 2020. F3 · derivative.expiration_date: The restricted stock units vested on October 15, 2020. Read SEC document |
| October 15, 2020 Filed Oct 19, 2020 20:25 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | GrantCommon Stock | 7,334 | $10.36 | $75,980.24 |
DisclosureSEC source: 0001593968-20-002074 · primary_01.xml · nonDerivative · entry 1 HOUDE LOVAS KATRINA · CIK 0001269294 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,334 F1 · price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. Read SEC document |
| July 31, 2020 Filed Aug 4, 2020 23:27 UTC | SunOpta Inc. STKL · Entity 49798 | GrantCommon Shares | 2,646 | $4.68 | $12,383.28 |
DisclosureSEC source: 0001209191-20-044894 · doc4.xml · nonDerivative · entry 1 HOUDE LOVAS KATRINA · CIK 0001269294 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 198,896 F1 · kind: The shares were issued in lieu of cash to the reporting person for service on the board of directors. Read SEC document |
| June 22, 2020 Filed Jun 24, 2020 22:22 UTC | SunOpta Inc. STKL · Entity 49798 | GrantRestricted Stock Units · Derivative | 19,547 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-038779 · doc4.xml · derivative · entry 1 HOUDE LOVAS KATRINA · CIK 0001269294 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,547 Underlying: Common Shares · 19,547 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of STKL common stock. F2 · derivative.expiration_date: The Restricted Stock Units do not have an expiration date. Read SEC document |
| June 14, 2020 Filed Jun 17, 2020 01:03 UTC | SunOpta Inc. STKL · Entity 49798 | Exercise / conversionRestricted Stock Units · Derivative | 24,194 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-037155 · doc4.xml · derivative · entry 3 HOUDE LOVAS KATRINA · CIK 0001269294 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 24,194 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of STKL common stock. F2 · derivative.expiration_date: The Restricted Stock Units do not have an expiration date. Read SEC document |
| June 14, 2020 Filed Jun 17, 2020 01:03 UTC | SunOpta Inc. STKL · Entity 49798 | Tax withholdingCommon Shares | 12,952 | $4.51 | $58,413.52 |
DisclosureSEC source: 0001209191-20-037155 · doc4.xml · nonDerivative · entry 2 HOUDE LOVAS KATRINA · CIK 0001269294 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 196,250 Read SEC document |
| June 14, 2020 Filed Jun 17, 2020 01:03 UTC | SunOpta Inc. STKL · Entity 49798 | Exercise / conversionCommon Shares | 24,194 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-037155 · doc4.xml · nonDerivative · entry 1 HOUDE LOVAS KATRINA · CIK 0001269294 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 209,202 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents a contingent right to receive one share of STKL common stock. Read SEC document |
| June 01, 2020 Filed Jun 2, 2020 22:19 UTC | LIFECORE BIOMEDICAL, INC. \DE\ LNDC · Entity 6447 | GrantRight to Buy Restricted Stock Unit (RSU) · Derivative | 8,303 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-20-008842 · wf-form4_159113632838951.xml · derivative · entry 1 HOUDE LOVAS KATRINA · CIK 0001269294 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,303 Underlying: Common Stock · 8,303 shares Expires not disclosed F1 · derivative.exercise_price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F1 · price: The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis. F2 · derivative.expiration_date: Restricted Stock Units will vest on the 1st anniversary of the grant date and will be automatically settled in shares of common stock. Read SEC document |
| May 08, 2020 Filed May 13, 2020 00:41 UTC | SunOpta Inc. STKL · Entity 49798 | GrantStock Option (right to buy) · Derivative | 3,076 | $3.25 Strike: $3.25 | $9,997.00 |
DisclosureSEC source: 0001209191-20-028680 · doc4.xml · derivative · entry 1 HOUDE LOVAS KATRINA · CIK 0001269294 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,076 Underlying: Common Shares · 3,076 shares Expires 2030-05-08 Read SEC document |
| May 08, 2020 Filed May 21, 2020 18:02 UTC Amendment | SunOpta Inc. STKL · Entity 49798 | GrantStock Option (right to buy) · Derivative | 5,830 | $0.00 Strike: $3.25 | $0.00 |
DisclosureSEC source: 0001209191-20-031169 · doc4a.xml · derivative · entry 1 HOUDE LOVAS KATRINA · CIK 0001269294 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,830 Underlying: Common Shares · 5,830 shares Expires 2030-05-08 F1 · shares: The original Form 4 filed on May 12, 2020, is amended by this Form 4 amendment to correctly reflect the price and the number of derivative securities acquired by the reporting person. F1 · price: The original Form 4 filed on May 12, 2020, is amended by this Form 4 amendment to correctly reflect the price and the number of derivative securities acquired by the reporting person. F1 · derivative.underlying_shares: The original Form 4 filed on May 12, 2020, is amended by this Form 4 amendment to correctly reflect the price and the number of derivative securities acquired by the reporting person. F1 · balance_after: The original Form 4 filed on May 12, 2020, is amended by this Form 4 amendment to correctly reflect the price and the number of derivative securities acquired by the reporting person. Read SEC document |
| April 24, 2020 Filed Apr 28, 2020 20:59 UTC | SunOpta Inc. STKL · Entity 49798 | GrantCommon Shares | 6,876 | $1.77 | $12,170.52 |
DisclosureSEC source: 0001209191-20-025977 · doc4.xml · nonDerivative · entry 1 HOUDE LOVAS KATRINA · CIK 0001269294 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 185,008 F1 · kind: The shares were issued in lieu of cash to the reporting person for service on the board of directors. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.